SKIN INFECTIONS (echinacea- angustifolia, phytolacca decandra, hepar sulphuris calcareum, mercurius solubilis, mezereum, ailanthus glandulosus, arsenicum album, lachesis mutus, herpes simplex i and ii nosode, herpes zoster nosode liquid

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Buy It Now

Active ingredient:

ECHINACEA ANGUSTIFOLIA (UNII: VB06AV5US8) (ECHINACEA ANGUSTIFOLIA - UNII:VB06AV5US8), PHYTOLACCA AMERICANA ROOT (UNII: 11E6VI8VEG) (PHYTOLACCA AMERICANA ROOT - UNII:11E6VI8VEG), CALCIUM SULFIDE (UNII: 1MBW07J51Q) (CALCIUM SULFIDE - UNII:1MBW07J51Q), MERCURIUS SOLUBILIS (UNII: 324Y4038G2) (MERCURIUS SOLUBILIS - UNII:324Y4038G2), DAPHNE MEZEREUM BARK (UNII: X2N6E405GV) (DAPHNE MEZEREUM BARK - UNII:X2N6E405GV), AILANTHUS ALTISSIMA FLOWERING TWIG (UNII: 8P29O5P7XU) (AILANTHUS ALTISSIMA FLOWERING TWIG - UNII:8P29O5P7XU), ARSENIC TRIOXIDE (UNII: S7V92P67HO) (ARSENIC CATION (3+) - UNII:C96613F5AV), LACHESIS MUTA VENOM (UNII: VSW71SS07I) (LACHESIS MUTA VENOM - UNII:VSW71SS07I), HUMAN HERPESVIRUS 1 (UNII: 22G38P19RL) (HUMAN HERPESVIRUS 1 - UNII:22G38P19RL), HUMAN HERPESVIRUS 2 (UNII: 74J6DNH49U) (HUMAN HERPESVIRUS 2 - UNII:74J6DNH49U), HUMAN HERPESVIRUS 3 (UNII: 9885M7D6JP) (HUMAN HERPESVIRUS 3 - UNII:9885M7D6JP)

Available from:

Deseret Biologials, Inc.

Administration route:

ORAL

Prescription type:

OTC DRUG

Therapeutic indications:

For temporary relief of symptoms related to skin infections including inflammation, rash, fever and swelling.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration. For temporary relief of symptoms related to skin infections including inflammation, rash, fever and swelling.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Authorization status:

unapproved homeopathic

Summary of Product characteristics

                                SKIN INFECTIONS- ECHINACEA (ANGUSTIFOLIA), PHYTOLACCA DECANDRA, HEPAR
SULPHURIS CALCAREUM, MERCURIUS SOLUBILIS, MEZEREUM, AILANTHUS
GLANDULOSUS,
ARSENICUM ALBUM, LACHESIS MUTUS, HERPES SIMPLEX I AND II NOSODE,
HERPES
ZOSTER NOSODE LIQUID
DESERET BIOLOGIALS, INC.
_Disclaimer: This homeopathic product has not been evaluated by the
Food and Drug_
_Administration for safety or efficacy. FDA is not aware of scientific
evidence to support_
_homeopathy as effective._
----------
DRUG FACTS:
ACTIVE INGREDIENTS:
Echinacea (Angustifolia) 3X, Phytolacca Decandra 4X, Hepar Sulphuris
Calcareum 8X,
Mercurius Solubilis 8X, Mezereum 9X, Ailanthus Glandulosus 10X,
Arsenicum Album 12X,
Lachesis Mutus 12X, Herpes Simplex I & II Nosode 15X, Herpes Zoster
Nosode 15X.
HOMEOPATHIC INDICATIONS:
For temporary relief of symptoms related to skin infections including
inflammation, rash,
fever and swelling.**
**These statements are based upon homeopathic principles. They have
not been
reviewed by the Food and Drug Administration.
WARNINGS:
KEEP OUT OF REACH OF CHILDREN. In case of overdose, contact physician
or Poison
Control Center right away.
IF PREGNANT OR BREAST-FEEDING, seek advice of a health professional
before use.
Tamper seal: "Sealed for Your Protection." Do not use if seal is
broken or missing.
KEEP OUT OF REACH OF CHILDREN:
KEEP OUT OF REACH OF CHILDREN. In case of overdose, contact physician
or Poison
Control Center right away.
DIRECTIONS:
1-10 drops under the tongue, 3 times a day or as directed by a health
professional.
Consult a physician for use in children under 12 years of age.
HOMEOPATHIC INDICATIONS:
For temporary relief of symptoms related to skin infections including
inflammation, rash,
fever and swelling.**
**These statements are based upon homeopathic principles. They have
not been
reviewed by the Food and Drug Administration.
INACTIVE INGREDIENTS:
Demineralized Water, 25% Ethanol.
QUESTIONS:
Dist. By: Deseret Biologicals, Inc.
469 W. Parkland Drive
Sandy, UT 84070 www.desbio.com
PACKAGE LABEL DISPLAY:
DESBIO
NDC 4374
                                
                                Read the complete document